CIK: 1534986 - Address: C/O Design Therapeutics, Inc., 6005 Hidden Valley Road, Suite 110, Carlsbad, CA 92011
9 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y
12/21/22 17:00
12/19/22
DSGNDesign Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsSiffert Joao MdCADOP,CEOP.m638.39076133D
12/22/14 20:07
12/18/14
AVNRAvanir Pharmaceuticals, Inc.DEHealthDrugPharmaceutical PreparationsSiffert Joao MdCAOSVP,R,DM.d842.5903211314D
12/22/14 20:07
12/18/14
AVNRAvanir Pharmaceuticals, Inc.DEHealthDrugPharmaceutical PreparationsSiffert Joao MdCAOSVP,R,DS.d-26316.930-16-5314D
10/24/14 20:48
10/24/14
AVNRAvanir Pharmaceuticals, Inc.DEHealthDrugPharmaceutical PreparationsSiffert Joao MdCAOSVP,R,DS-9911.800-8-4223D
5/30/14 20:00
5/28/14
AVNRAvanir Pharmaceuticals, Inc.DEHealthDrugPharmaceutical PreparationsSiffert Joao MdCAOSVP,R,DS.d-705.180-14-6231D
12/20/13 17:32
12/18/13
AVNRAvanir Pharmaceuticals, Inc.DEHealthDrugPharmaceutical PreparationsSiffert Joao MdCAOSVP,R,DS-162.630-6-5110D
9/19/13 20:50
9/18/13
AVNRAvanir Pharmaceuticals, Inc.DEHealthDrugPharmaceutical PreparationsSiffert Joao MdCAOSVP,R,DM.d391.8502122116D
9/19/13 20:50
9/18/13
AVNRAvanir Pharmaceuticals, Inc.DEHealthDrugPharmaceutical PreparationsSiffert Joao MdCAOSVP,R,DS.d-894.220-21-15116D
5/14/12 11:14
5/10/12
AVNRAvanir Pharmaceuticals, Inc.DEHealthDrugPharmaceutical PreparationsSiffert Joao MdCAOSVP,R,DP82.9603932D

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact